A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection

Acta Virologica

Volumn 50, Issue 2, 2006, Pages 87-92

  Gupta, R K ^a   Sharma, S ^a   Walunj, S S ^a   Patil, A A ^a   Rai, A ^a   Saini, M ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Antibody response; DNA vaccine; Glycoprotein; Mice; Protection; Rabies virus; Transmembrane domain

Indexed keywords

DNA VACCINE; VIRUS GLYCOPROTEIN; GLYCOPROTEIN; GLYCOPROTEIN G, RABIES VIRUS; IMMUNOGLOBULIN G; RABIES VACCINE; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RABIES VIRUS; ANIMAL; BAGG ALBINO MOUSE; BLOOD; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; PROTEIN TERTIARY STRUCTURE; RABIES; SURVIVAL;

MUS; RABIES VIRUS;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PROTEIN STRUCTURE, TERTIARY; RABIES; RABIES VACCINES; RABIES VIRUS; SURVIVAL ANALYSIS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

EID: 33749051925     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Barry MA, Johnston SA (1997): Biological features of genetic immunization. Vaccine 15, 788-791.
2. Boyle JS, Koniaras C, Lew AM (1997): Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int. Immunol. 12, 1897-1906.
3. Celis E, Ou D, Dietzschold B, Koprowski H (1988): Recognition of rabies and rabies-related virus by T cells derived from human vaccine recipients. J. Virol. 62, 3128-3134.
4. Chen SC, Jones DH, Fynan EF, Farrar GH, Clegg JC, Greenberg HB, Herrmann JE (1998): Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J. Virol. 72, 5757-5761.
5. Cik M, Masure S, Lesage ASJ, Linden IV, Gompel PV, Pangalos MN, Gordon RD, Leysen JE (2000): Binding of GDNF and neurturin to human GDNF family receptor α 1 and 2. J. Biol. Chem. 275, 27505-27512.
6. Coll JM (1995): The glycoprotein G of rhabdoviruses. Arch. Virol. 140, 827-851.
7. Cox JH, Dietzschold B, Schneider LG (1977): Rabies virus glycoprotein II. Biological and serological characterization. Infect. Immun. 16, 754-759.
8. Day JM, Murdoch AD, Hardingha TE (1999): The folded protein modules of the C-terminal G3 domain of aggrecan can each facilitate the translocation and secretion of the extended chondroitin sulfate attachment sequence. J. Biol. Chem. 274, 38107-38111.
9. Dietzschold B, Ertl HC (1991): New developments in pre- and post-exposure treatment of rabies. Crit. Rev. Immunol. 10, 427-439.
10. Dietzschold B, Wiktor TJ, Wunner WH, Varrichio A (1983): Chemical and immunological analysis of the rabies soluble glycoprotein. Virology 124, 330-337.
11. Drew DR, Lightowlers M, Strugnell RA (2000): Humoral immune responses to DNA vaccines expressing secreted, membrane bound and non-secreted forms of the Taenia ovis 45W antigen. Vaccine 18, 2522-2532.
12. Gaudin Y, Ruigrok R, Tuffereau C, Knossow M, Flamand A (1992): Rabies glycoprotein is a trimer. Virology 187, 627-632.
13. Gregoriadis G (1998): Genetic vaccines: strategies for optimization. Pharm. Res. 15, 814-870.
14. Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B (1998): Collaboration of antibody and inflammation in the clearance of rabies virus from the CNS. J. Virol. 72, 3711-3719.
15. Inchauspe G, Vitvitski L, Major ME, Jung G, Spengler U, Maisonnas M, Trepo C (1997): Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol. 16, 185-195.
16. Iwasaki A, Stiernholm BJ, Chan AK, Berinstein NL, Barber BH (1997): Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158, 4591-4601.
17. Jones DH, Corris S, McDonald S, Clegg JC, Farrar GH (1997): Poly (DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine 15, 814-817.
18. Kuhrober A, Wild J, Pudollek HP, Chisari FV, Reimann J (1997): DNA vaccination with plasmid encoding the intracellular (HBsAg) or secreted (HBcAg) from of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb and Kd-restricted epitopes. Int. Immunol. 9, 1203-1212.
19. Lewis PJ, van Drunen Littel-van den Hurk S, Babiuk LA (1999): Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J. Virol. 12, 14-23.
20. Lodmell DL, Ewalt LC (2000): Rabies vaccination: comparison of neutralizing antibody responses after priming and boosting with different combinations of DNA, inactivated virus, or recombinant vaccinia virus vaccines. Vaccine 18, 2394-2398.
21. Lodmell DL, Ewalt LC (2001): Post-exposure DNA vaccination protects mice against rabies virus. Vaccine 19, 2468-2473.
22. Lodmell DL, Ray NB, Ewalt LC (1998): Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies infection. Vaccine 16, 115-118.
23. Macfarlan RI, Dietzschold B, Koprowski H (1986): Stimulation of cytotoxic T-lymphocyte responses by rabies virus glycoprotein and identification of an immunodominant domain. Mol. Immunol. 23, 733-741.
24. Morel PA, Falkner D, Plowey J, Larregina AT, Falo LD (2004): DNA immunisation: altering the cellular localisation of expressed protein and the immunisation route allows manipulation of the immune response. Vaccine 22, 447-4-56.
25. Perrin P, Jacob Y, Aguilar-Setien A, Loza-Rubio E, Jallet C, Desmezieres E, Aubert M, Cliquet F, Tordo N (2000): Immunization of dogs with a DNA vaccine induces protection against rabies virus. Vaccine 18, 47-56.
26. Perrin P, Thibodeau L, Sureau P (1985): Rabies immunosomes (subunit vaccine) structure and immunogenicity. Pre- and post exposure protection studies. Vaccine 3, 325-332.
27. Perry LL, Lodmell DL (1991): Role of CD4+ and CD8+ T cells in murine resistance to street rabies virus. J. Virol. 65, 342-344.
28. Rai A (1985): Methods in Cell Culture and Virology. Allied Publishers, New Delhi.
29. Rath A, Choudhury S, Batra D, Kapre SV, Rupprecht CE, Gupta SK (2005): DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response. Virus Res. 113, 143-152.
30. Ray NB, Ewalt LC, Lodmell DL (1997): Nanogram quantities of plasmid DNA encoding the virus glycoprotein protect mice against lethal rabies virus infection. Vaccine 15, 82-85.
31. Robinson HL, Torres CA (1997): DNA vaccines. Semin. Immunol. 9, 271-283.
32. Sedegah M, Hedstrom R, Hobart P, Hoffman SL (1994): Protection against malaria by immunization with plasmid DNA encoding circumsporozoit protein. Proc. Natl. Acad. Sci. USA 91, 9866-9870.
33. Stingl G (1990): Dendritic cells of skin. Dermatol. Clin. 8, 673-679.
34. Vinner L, Nielsen HV, Bryder K, Corbet S, Nielsen C, Fomsgaard A (1999): Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp-160 envelope gene using mammalian codons. Vaccine 17, 2166-2175.
35. Xiang Z, Ertl HC (1995): Manipulation of immune response to a plasmid-encoded viral antigen by coinoculation with Plasmids expressing cytokines. Immunity 2, 129-135.
36. Xiang ZQ, Knowles BB, McCarrick JW, Ertl HC (1995): Immune effector mechanisms required for protection to rabies virus. Virology 214, 398-404.
37. Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Heng J, Ertl HC (1994): Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199, 132-140.